388 related articles for article (PubMed ID: 22538356)
1. Neuroprotection and estrogen receptors.
Simpkins JW; Singh M; Brock C; Etgen AM
Neuroendocrinology; 2012; 96(2):119-30. PubMed ID: 22538356
[TBL] [Abstract][Full Text] [Related]
2. Non-feminizing estrogens: a novel neuroprotective therapy.
Petrone AB; Gatson JW; Simpkins JW; Reed MN
Mol Cell Endocrinol; 2014 May; 389(1-2):40-7. PubMed ID: 24424441
[TBL] [Abstract][Full Text] [Related]
3. Interactions of estrogens and insulin-like growth factor-I in the brain: implications for neuroprotection.
Cardona-Gómez GP; Mendez P; DonCarlos LL; Azcoitia I; Garcia-Segura LM
Brain Res Brain Res Rev; 2001 Nov; 37(1-3):320-34. PubMed ID: 11744097
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons.
Zhao L; Wu TW; Brinton RD
Brain Res; 2004 Jun; 1010(1-2):22-34. PubMed ID: 15126114
[TBL] [Abstract][Full Text] [Related]
5. Estrogen activates classical and alternative mechanisms to orchestrate neuroprotection.
Marin R; Guerra B; Alonso R; Ramírez CM; Díaz M
Curr Neurovasc Res; 2005 Oct; 2(4):287-301. PubMed ID: 16181121
[TBL] [Abstract][Full Text] [Related]
6. Estrogen provides neuroprotection against activated microglia-induced dopaminergic neuronal injury through both estrogen receptor-alpha and estrogen receptor-beta in microglia.
Liu X; Fan XL; Zhao Y; Luo GR; Li XP; Li R; Le WD
J Neurosci Res; 2005 Sep; 81(5):653-65. PubMed ID: 16013043
[TBL] [Abstract][Full Text] [Related]
7. Effects of estrogen in the brain: is it a neuroprotective agent in Alzheimer's disease?
Correia SC; Santos RX; Cardoso S; Carvalho C; Santos MS; Oliveira CR; Moreira PI
Curr Aging Sci; 2010 Jul; 3(2):113-26. PubMed ID: 20167003
[TBL] [Abstract][Full Text] [Related]
8. Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease.
Zhao L; Brinton RD
BMC Neurosci; 2006 Mar; 7():24. PubMed ID: 16533397
[TBL] [Abstract][Full Text] [Related]
9. Extranuclear estrogen receptors mediate the neuroprotective effects of estrogen in the rat hippocampus.
Yang LC; Zhang QG; Zhou CF; Yang F; Zhang YD; Wang RM; Brann DW
PLoS One; 2010 May; 5(5):e9851. PubMed ID: 20479872
[TBL] [Abstract][Full Text] [Related]
10. Estrogens and neuroprotection in retinal diseases.
Kumar DM; Simpkins JW; Agarwal N
Mol Vis; 2008 Aug; 14():1480-6. PubMed ID: 18698377
[TBL] [Abstract][Full Text] [Related]
11. A novel mechanism of non-feminizing estrogens in neuroprotection.
Engler-Chiurazzi EB; Covey DF; Simpkins JW
Exp Gerontol; 2017 Aug; 94():99-102. PubMed ID: 27818250
[TBL] [Abstract][Full Text] [Related]
12. Oestrogen receptor subtype-specific repression of calpain expression and calpain enzymatic activity in neuronal cells--implications for neuroprotection against Ca-mediated excitotoxicity.
Gamerdinger M; Manthey D; Behl C
J Neurochem; 2006 Apr; 97(1):57-68. PubMed ID: 16524385
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective properties of selective estrogen receptor agonists in cultured neurons.
Cordey M; Pike CJ
Brain Res; 2005 May; 1045(1-2):217-23. PubMed ID: 15910780
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
Katzenellenbogen BS; Choi I; Delage-Mourroux R; Ediger TR; Martini PG; Montano M; Sun J; Weis K; Katzenellenbogen JA
J Steroid Biochem Mol Biol; 2000 Nov; 74(5):279-85. PubMed ID: 11162936
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotection by ovarian hormones in animal models of neurological disease.
Hoffman GE; Merchenthaler I; Zup SL
Endocrine; 2006 Apr; 29(2):217-31. PubMed ID: 16785598
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor-independent neuroprotection via protein phosphatase preservation and attenuation of persistent extracellular signal-regulated kinase 1/2 activation.
Yi KD; Cai ZY; Covey DF; Simpkins JW
J Pharmacol Exp Ther; 2008 Mar; 324(3):1188-95. PubMed ID: 18089844
[TBL] [Abstract][Full Text] [Related]
17. Structure-nongenomic neuroprotection relationship of estrogens and estrogen-derived compounds.
Prokai L; Simpkins JW
Pharmacol Ther; 2007 Apr; 114(1):1-12. PubMed ID: 17336390
[TBL] [Abstract][Full Text] [Related]
18. Single-chain estrogen receptors (ERs) reveal that the ERalpha/beta heterodimer emulates functions of the ERalpha dimer in genomic estrogen signaling pathways.
Li X; Huang J; Yi P; Bambara RA; Hilf R; Muyan M
Mol Cell Biol; 2004 Sep; 24(17):7681-94. PubMed ID: 15314175
[TBL] [Abstract][Full Text] [Related]
19. Oestrogen as a neuroprotective hormone.
Behl C
Nat Rev Neurosci; 2002 Jun; 3(6):433-42. PubMed ID: 12042878
[TBL] [Abstract][Full Text] [Related]
20. The assessment of non-feminizing estrogens for use in neuroprotection.
Yi KD; Perez E; Yang S; Liu R; Covey DF; Simpkins JW
Brain Res; 2011 Mar; 1379():61-70. PubMed ID: 21111714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
